Medical Review Policy

Who reviews our clinical content, and how.

Who reviews

Dr. Anjmun Sharma, MD, board-focused in bariatrics, oversees and reviews the clinical content of New Hope Weight Loss / Nueva Figura.

The process

Every clinical page is checked for accuracy, honest compounded-medication framing, and alignment with the cited primary sources, before publication and again when guidelines or regulations change.

Not individual advice

Our content is educational and is not a substitute for a personalized medical consultation. A physician sets your plan based on your full history.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.